首页> Bioscience trends> Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.

Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lei,Liu

第一单位： Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University.;Department of Urology, Weihai Municipal Hospital.

作者： Lei,Liu ^[1] ; Renbo,Guo ^[2] ; Xiang,Zhang ^[3] ; Yiran,Liang ^[4] ; Feng,Kong ^[5] ; Jue,Wang ^[5] ; Zhonghua,Xu ^[3]

作者单位： Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University.;Department of Urology, Weihai Municipal Hospital. ^[1] Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University.;Department of Urology, Shandong Cancer Hospital and Institute. ^[2] Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University.;Department of Urology, Qilu Hospital of Shandong University. ^[3] Institute of Basic Medical Science and Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital of Shandong University.;Department of Breast Surgery, Qilu Hospital of Shandong University. ^[4] Central Laboratory, The Second Hospital of Shandong University. ^[5]

关键词 H3K36me3 SET domain-containing protein 2 clear cell renal cell carcinoma prognosis